FindTrial
Sign In

Clinic study for epidural labor analgesia of puerpera by Nalbuphine

Clinic study for epidural labor analgesia of puerpera by Nalbuphine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019220
Enrollment
Unknown
Registered
2018-10-31
Start date
2018-11-02
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor analgesia

Interventions

SR:sufentanil
NR:nalbuphine

Sponsors

Hu'nan Hengyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Expected time study from November 2018 to October 2020 in hengyang central hospital and hengyang health care centers for women and children who do epidural primipara, head, singletons, gestational age 37 ~ 41 weeks, ASA class I-II, maternal aged 18 to 45 years old, no anesthesia intra-spinal canal contraindicated, opioids, local anesthetic drug allergy history

Exclusion criteria

Exclusion criteria: We refuse to perform epidural labor analgesia, pre-eclampsia, combined cardiovascular disease, history of cesarean delivery, chronic pain, lumbar and leg pain, spinal deformity, previous history of epidural or subarachnoid anesthesia, and use of analgesic drugs

Design outcomes

Primary

MeasureTime frame
Visual Analogue Score;nausea and vomiting;Urinary retention;Apgar score;—

Secondary

MeasureTime frame
Blood pressure;Heart rate;Analysis of cord blood;—

Countries

China

Contacts

Public ContactDianxiang Tan

Hu'nan Hengyang Central Hospital

dxtan2005@126.com+86 13875782871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026